Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Sat, 17 Aug 2019 17:49:00 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Lynparza Phase III PAOLA-1 trial met primary endpo ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190814070008_14187893 Wed, 14 Aug 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190814070008_14187893 <![CDATA[RNS press release - Calquence granted US Breakthrough Therapy Designat ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190814070007_14187889 Wed, 14 Aug 2019 07:00:07 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190814070007_14187889 <![CDATA[RNS press release - Amendment: Tagrisso significantly improves overall ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190809092852_14183327 Fri, 09 Aug 2019 09:28:52 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190809092852_14183327 <![CDATA[RNS press release - Tagrisso significantly improves overall survival ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190809070004_14182659 Fri, 09 Aug 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190809070004_14182659 <![CDATA[RNS press release - Lynparza Phase III PROfound trial in HRR* ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190807070006_14179024 Wed, 07 Aug 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190807070006_14179024 <![CDATA[RNS press release - Forxiga label updated in the EU in type-2 diabetes ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190805070006_14175508 Mon, 05 Aug 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190805070006_14175508 <![CDATA[RNS press release - Total Voting Rights ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190801150001_14173164 Thu, 01 Aug 2019 15:00:01 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190801150001_14173164 <![CDATA[RNS press release - AZN: H1 2019 Results ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190725070011_14162260 Thu, 25 Jul 2019 07:00:11 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190725070011_14162260 <![CDATA[RNS press release - Update on US regulatory decision for Farxiga ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190715070006_14148529 Mon, 15 Jul 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190715070006_14148529 <![CDATA[RNS press release - Imfinzi granted US Orphan Drug Designation for ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190712070003_14145979 Fri, 12 Jul 2019 07:00:03 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190712070003_14145979 <![CDATA[RNS press release - Total Voting Rights ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190701150001_14131813 Mon, 01 Jul 2019 15:00:01 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190701150001_14131813 <![CDATA[RNS press release - Fasenra receives positive EU CHMP opinion for self ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190701070008_14130278 Mon, 01 Jul 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190701070008_14130278 <![CDATA[RNS press release - Forxiga receives positive EU CHMP opinion for ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190701070008_14130281 Mon, 01 Jul 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190701070008_14130281 <![CDATA[RNS press release - Imfinzi improves overall survival at interim ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190627070012_14127257 Thu, 27 Jun 2019 07:00:12 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190627070012_14127257 <![CDATA[RNS press release - Breztri Aerosphere (PT010) approved in Japan for ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190619070004_14115854 Wed, 19 Jun 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190619070004_14115854 <![CDATA[RNS press release - Lynparza approved in Japan for 1st-line ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190619070004_14115845 Wed, 19 Jun 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190619070004_14115845 <![CDATA[RNS press release - Bevespi Aerosphere approved by the Japanese ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190619070004_14115843 Wed, 19 Jun 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190619070004_14115843 <![CDATA[RNS press release - Lynparza approved in the EU for 1st-line ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190618070012_14114121 Tue, 18 Jun 2019 07:00:12 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190618070012_14114121 <![CDATA[RNS press release - Calquence significantly prolonged the time patient ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190617070006_14112397 Mon, 17 Jun 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190617070006_14112397 <![CDATA[RNS press release - Publication of a Prospectus ]]> https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190612164504_14108763 Wed, 12 Jun 2019 16:45:04 +0100 https://www.proactiveinvestors.co.uk/LON:AZN/AstraZeneca/rns/LSE20190612164504_14108763